IP leverage for biotechnical innovations

Library / Case Study

Printer-friendly versionPDF version

Biotechnology is a field where technology advances rapidly. For this reason, it is vital for any company operating in this sector to protect the innovations that they generate with Intellectual Property Rights (IPR).

In this case study you can see the example of Keygene, an SME that has been able to reap the entire benefit from their intellectual property capital by setting an IP strategy from the outset in line with their core business and put it into operational phases via proper IP management.

Thanks to this IP awareness and the implementation and constant revision of the company’s IP strategy, Keygene is leading the agro-food biotech sector in the EU market. Furthermore, they succeeded in expanding their B2B activities, supplying their products to seeds companies worldwide.

Download the publication:
EN